Patent · US Active

Therapeutic human anti-IL-1R1 monoclonal antibody

US8710203B2 · kind B2 · utility

0Cited by

17References

24Claims

0Family size

Assignees

AMGEN INC. · US
MEDAREX, L.L.C. · US

Inventors

Brian Varnum · Santa Monica, US
Chris Vezina · Newbury Park, US
Alison Witte · Scotts Valley, US
Xueming Qian · Thousand Oaks, US
Francis H. Martin · Newbury Park, US
Haichun Huang · Fremont, US
Gary Elliot · Stevensville, US

Key dates

Filing date	Aug 7, 2013
Grant date	Apr 29, 2014
Priority date	—
Expiry date	Aug 7, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.